AEVI GENOMIC MEDICINE, INC.

Profile

Company Names

AEVI GENOMIC MEDICINE, INC.
MEDGENICS, INC.

Addresses

435 DEVON PARK DRIVE,, SUITE 715, WAYNE, PA 19087

435 DEVON PARK DRIVE, BLDG. 700, WAYNE, PA 19087

555 CALIFORNIA STREET, SUITE 365, SAN FRANCISCO, CA 94104

TERADION BUSINESS PK., MISGAV, L3 20179

Phone Numbers

610-254-4201
415-568-2245
1-646-239-1690

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$45,426,066.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2017-10-17 
$28,000,000.00 
$28,000,000.00 
$0.00 
Equity 
5
2015-10-06 
$3,200,000.00 
$3,200,000.00 
$0.00 
Equity 
4
2012-06-18 
$9,529,196.00 
$9,529,382.00 
$186.00 
Equity 
3
2010-09-22 
$4,001,500.00 
$4,001,500.00 
$0.00 
Debt 
2
2010-05-25 
$430,370.00 
$430,370.00 
$0.00 
Equity 
1
2009-06-16 
$265,000.00 
$5,000,000.00 
$4,735,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SCOTT 
 
APPLEBAUM 
EXECUTIVE OFFICER
EUGENE 
ANDREW 
BAUER 
DIRECTOR
EUGENE 
ANDREW 
BAUER, MD 
DIRECTOR
PHYLLIS 
 
BELLIN 
EXECUTIVE OFFICER
STEPHEN 
 
BELLOMO 
EXECUTIVE OFFICER
GARY 
ALLAN 
BRUKARDT 
DIRECTOR
ALASTAIR 
 
CLEMOW 
DIRECTOR
ALASTAIR 
 
CLEMOW, PHD 
DIRECTOR
MICHAEL 
F. 
COLA 
EXECUTIVE OFFICER, DIRECTOR
CLARENCE 
L. 
DELLIO 
EXECUTIVE OFFICER
WILBUR 
H. 
GANTZ 
DIRECTOR
WILBUR 
H. 
GANTZ III 
DIRECTOR
JOSEPH 
J. 
GRANO JR. 
DIRECTOR
JOEL 
STEPHEN 
KANTER 
DIRECTOR
JOHN 
H. 
LEAMAN 
EXECUTIVE OFFICER
STEPHEN 
DEVON 
MCMURRAY 
DIRECTOR
STEPHEN 
DEVON 
MCMURRAY, MD 
DIRECTOR
GARRY 
A. 
NEIL 
EXECUTIVE OFFICER
ANDREW 
LEONARD 
PEARLMAN 
EXECUTIVE OFFICER, DIRECTOR
ANDREW 
LEONARD 
PEARLMAN, PHD 
EXECUTIVE OFFICER, DIRECTOR
EHUD 
 
SHOSHANI 
EXECUTIVE OFFICER
LEONARD 
 
STEINBERG 
DIRECTOR
BARUCH 
 
STERN 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2017-10-17 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-10-06 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2012-06-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-25 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2009-06-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MAXIM GROUP LLC
NA
NONE
MAXIM GROUP LLC
NONE
NONE
EQUITY SOURCE PARTNERS, LLC
NEWBRIDGE SECURITIES CORPORATION
NEWBRIDGE SECURITIES CORPORATION